• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白受体概念的演变——从培养细胞到完整动物

Evolution of the LDL receptor concept-from cultured cells to intact animals.

作者信息

Brown M S, Kovanen P T, Goldstein J L

出版信息

Ann N Y Acad Sci. 1980;348:48-68. doi: 10.1111/j.1749-6632.1980.tb21290.x.

DOI:10.1111/j.1749-6632.1980.tb21290.x
PMID:6994567
Abstract

The initial observations in cultured fibroblasts made six years ago allowed the formulation of a series of hypotheses concerning LDL metabolism in tissues of animals and man. The most important of these hypotheses was that a large fraction of LDL was removed from plasma by a specific receptor-mediated uptake mechanism whose function was to supply cholesterol to extrahepatic cells. This hypothesis is strongly supported by genetic observations in patients with familial hypercholesterolemia and by studies of the four model systems discussed above. These studies by no means solve all of the important questions about LDL metabolism. We still need to know which tissues take up the most LDL; we need to know how much LDL is cleared by the liver and whether this clearance involves the same LDL receptor that operates in extra-hepatic cells; we need to know the mechanism for the clearance of the one-half to two-thirds of LDL that leaves the plasma by receptor-independent pathways; and finally we need to know how an abnormal accumulation of LDL in the plasma leads to the deposition of cholesterol in scavenger cells and produces atherosclerosis.

摘要

六年前在培养的成纤维细胞中进行的初步观察,使得一系列关于动物和人类组织中低密度脂蛋白(LDL)代谢的假说得以形成。这些假说中最重要的一点是,很大一部分LDL是通过一种特定的受体介导摄取机制从血浆中清除的,其功能是为肝外细胞提供胆固醇。家族性高胆固醇血症患者的遗传学观察以及上述四种模型系统的研究,都有力地支持了这一假说。这些研究远未解决所有关于LDL代谢的重要问题。我们仍然需要知道哪些组织摄取的LDL最多;我们需要知道肝脏清除了多少LDL,以及这种清除是否涉及在肝外细胞中起作用的相同LDL受体;我们需要知道通过非受体依赖途径离开血浆的LDL的一半到三分之二的清除机制;最后,我们需要知道血浆中LDL的异常积累是如何导致胆固醇在吞噬细胞中沉积并产生动脉粥样硬化的。

相似文献

1
Evolution of the LDL receptor concept-from cultured cells to intact animals.低密度脂蛋白受体概念的演变——从培养细胞到完整动物
Ann N Y Acad Sci. 1980;348:48-68. doi: 10.1111/j.1749-6632.1980.tb21290.x.
2
The LDL pathway in human fibroblasts: a receptor-mediated mechanism for the regulation of cholesterol metabolism.
Curr Top Cell Regul. 1976;11:147-81. doi: 10.1016/b978-0-12-152811-9.50011-0.
3
Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.正常及纯合子家族性高胆固醇血症患者肝脏低密度脂蛋白结合及胆固醇代谢特征
J Clin Invest. 1984 Feb;73(2):429-36. doi: 10.1172/JCI111229.
4
WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia.WHHL兔:一种用于家族性高胆固醇血症的低密度脂蛋白受体缺陷动物模型。
FEBS Lett. 1980 Aug 25;118(1):81-4. doi: 10.1016/0014-5793(80)81223-3.
5
The metabolic basis of familial hypercholesterolemia.家族性高胆固醇血症的代谢基础。
Klin Wochenschr. 1983 Apr 15;61(8):383-401. doi: 10.1007/BF01488153.
6
[Disorders of lipoprotein and cholesterol metabolism in familial hypercholesterolemia].家族性高胆固醇血症中的脂蛋白和胆固醇代谢紊乱
Pol Arch Med Wewn. 1982 Jan-Feb;67(1-2):47-52.
7
Familial hypercholesterolemia. Evidence for a newly recognized mutation determining increased fibroblast receptor affinity but decreased capacity for low density lipoprotein in two siblings.家族性高胆固醇血症。两个兄弟姐妹中存在一种新发现突变的证据,该突变决定了成纤维细胞受体亲和力增加但低密度脂蛋白能力降低。
J Clin Invest. 1982 Oct;70(4):823-31. doi: 10.1172/jci110678.
8
Intracellular cholesterol accumulation and coenzyme Q deficiency in Familial Hypercholesterolemia.家族性高胆固醇血症患者的细胞内胆固醇蓄积和辅酶 Q 缺乏。
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3697-3713. doi: 10.1016/j.bbadis.2018.10.009. Epub 2018 Oct 5.
9
Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia.
Arteriosclerosis. 1982 Jul-Aug;2(4):303-11. doi: 10.1161/01.atv.2.4.303.
10
Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.低密度脂蛋白受体在调节人成纤维细胞中游离胆固醇和酯化胆固醇含量方面的作用。
J Clin Invest. 1975 Apr;55(4):783-93. doi: 10.1172/JCI107989.

引用本文的文献

1
Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.用于鉴定治疗脑海绵状血管畸形的药物新用途的策略。
Circulation. 2015 Jan 20;131(3):289-99. doi: 10.1161/CIRCULATIONAHA.114.010403. Epub 2014 Dec 8.
2
Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.砷剂(美拉胂醇)、喷他脒和苏拉明用于治疗人类非洲锥虫病。
Parasitol Res. 2003 May;90(1):71-9. doi: 10.1007/s00436-002-0799-9. Epub 2003 Jan 31.
3
Stimulation of hepatic squalene and triglyceride synthesis by dimethylsulfoxide, in vitro.
二甲基亚砜对肝脏角鲨烯和甘油三酯合成的体外刺激作用。
Lipids. 1982 Dec;17(12):900-4. doi: 10.1007/BF02534585.
4
Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes.胰岛素和葡萄糖对培养的大鼠肝细胞极低密度脂蛋白甘油三酯分泌的影响。
J Clin Invest. 1982 Jul;70(1):63-73. doi: 10.1172/jci110604.
5
[The apolipoproteins in man ].[人类中的载脂蛋白]
Klin Wochenschr. 1982 Jul 1;60(13):673-49. doi: 10.1007/BF01716796.
6
Raman studies of structural rearrangements induced in human plasma lipoprotein carotenoids by malondialdehyde.
Lipids. 1985 Dec;20(12):890-6. doi: 10.1007/BF02534773.
7
Plasma apolipoproteins and lipids in normal persons and patients with hypertension.正常人和高血压患者的血浆载脂蛋白及脂质
Korean J Intern Med. 1986 Jul;1(2):214-21. doi: 10.3904/kjim.1986.1.2.214.
8
Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis.锌(II)-酞菁作为肿瘤的光动力剂。II. 光致敏肿瘤坏死机制的研究。
Br J Cancer. 1990 Jun;61(6):846-50. doi: 10.1038/bjc.1990.189.